Condition: Hypertension · Vascular Diseases · Cardiovascular Diseases · Sponsor: Medtronic Vascular
The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.
This description comes directly from the study's public registry record.
Cecile Mahoney · +17635051057 · Cecile.C.Mahoney@medtronic.com
Always discuss trial participation with your own doctor first.
| Stanford Hospital and Clinics | Stanford, California, United States | Recruiting |
| Orlando Health Heart & Vascular Institute | Orlando, Florida, United States | Recruiting |
| BayCare Health System Mease Countryside Hospital | Safety Harbor, Florida, United States | Recruiting |
| Piedmont Heart Institute | Atlanta, Georgia, United States | Recruiting |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | Recruiting |
| Henry Ford Providence Hospital | Southfield, Michigan, United States | Recruiting |
| North Mississippi Medical Center | Tupelo, Mississippi, United States | Recruiting |
| Renown Regional Medical Center | Reno, Nevada, United States | Recruiting |
| Virtua Our Lady of Lourdes Hospital | Camden, New Jersey, United States | Recruiting |
| University of North Carolina (UNC) Memorial Hospital | Chapel Hill, North Carolina, United States | Recruiting |
| Baylor Heart & Vascular Hospital | Dallas, Texas, United States | Recruiting |
| UT Health East Texas | Tyler, Texas, United States | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06907147